Form 4 for HNVR Hanover Bancorp, Inc. /MD
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001619964-24-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-05 | 2024-03-01 | HNVR | Katz Michael David M.D. | Dir | A - Grant | $0.00 | +2,117 | 147.2K | +1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | A | A | 2,117 | $0.00 | 147,222 | D | — | — | (F1) Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of March 1, 2025, March 1, 2026, March 1, 2027, March 1, 2028, and March 1, 2029 |